Oncology

Taking steps to improve customer satisfaction may increase oncology revenue for manufacturers.

Agents fight cancer by temporarily loosening DNA, increasing the expression of tumor suppressors, and making the tumor more vulnerable.

Top news of the day from across the health care landscape.

Method could help provide more personalized treatments for patients with skin cancer.

Tests provide little to no benefit and can increase a breast cancer patient’s financial burden.

Sharing cancer data can save lives.

Top news of the day from across the health care landscape.

Time to treatment initiation of cancer treatment increased between 2004 and 2013 from 21 days to 29 days, respectively.

Collaboration between Novartis and IBM Watson Health integrates real-world data and analytical techniques on breast cancer outcomes.

Up to 50% of patients with HER2-positive breast cancer treated with targeted therapies develop brain metastases.

An experimental drug reactivated an enzyme to elicit tumor suppression.

Targeting PP2A enzyme shows promise treating lung cancer.

Continuous low-dose cisplatin through an implantable device could be a therapeutic option in for patients with ovarian cancer.

Top news of the day from across the health care landscape.

Top news of the week in oncology and cancer drug development.

As chemotherapy resistance builds, cancer cells develop a new Achilles’ heel.

Copies of the androgen receptor gene could indicate response to standard prostate cancer drugs.

A look at last weeks top stories in the world of pharmacy.

Immune checkpoint inhibitors have revolutioned cancer treatment, but not all patients respond to immunotherapy.

Scientists found that some breast cancer patients have a co-occurrence of genetic mutations.

Wider access to new direct-acting antivirals for people who inject drugs may help reduce HCV infections.

Immunotherapies have improved survival in cancer patients.

Flood of new drug approvals have extended survival across cancer types.

While incidences of metastatic breast cancer are increasing, so is survival.

Scientists redesigned a portion of rituximab into a new molecule to treat amyotrophic lateral sclerosis.

A compound in aged cheese, mushrooms, and whole grains found to increase life span by 25% in animal models.

GLUT1 inhibitors could be a potential therapeutic target for the squamous subtype of cancer.

Society for Integrative Oncology releases updated clinical guidelines on integrative breast cancer treatments.